METRN and ischemic stroke: This reveals a novel biological function for Meteorin in vivo and indicates therapeutic potential in pathological settings involving loss of oligodendrocytes—for example the demyelination of neurons resulting from loss of oligodendrocytes after ischemic stroke (Pantoni et al., 1996; Dewar et al., 2003).